According to our (Global Info Research) latest study, the global COPD Inhaler market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
COPD inhaler is a therapeutic device for patients with chronic obstructive pulmonary disease (COPD), designed to deliver inhaled medication directly into the patient"s lungs to improve respiratory symptoms and manage the disease. COPD inhalers are mainly used for the medication of COPD patients. COPD is a chronic lung disease that includes chronic bronchitis and emphysema. Inhalers are used to give patients inhaled medications to reduce airway inflammation, dilate airways, reduce mucus production, and help control symptoms such as shortness of breath, coughing, and expectoration.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report is a detailed and comprehensive analysis for global COPD Inhaler market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global COPD Inhaler market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global COPD Inhaler market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global COPD Inhaler market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global COPD Inhaler market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for COPD Inhaler
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global COPD Inhaler market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include TRELEGY, TTP, Consort Medical, Cambridge Consultants, Inhalexper, 3M, Hovione, Qualicaps, Catalent, Aerovance, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
COPD Inhaler market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Pressurized Metered Dose Inhaler
Dry Powder Inhaler
Soft Mist Inhaler
Atomizer
Market segment by Application
Hospital
Clinic
Pharmacy
Major players covered
TRELEGY
TTP
Consort Medical
Cambridge Consultants
Inhalexper
3M
Hovione
Qualicaps
Catalent
Aerovance
VertMarkets
Boehringer Ingelheim
AstraZeneca
Chiesi
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe COPD Inhaler product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of COPD Inhaler, with price, sales quantity, revenue, and global market share of COPD Inhaler from 2020 to 2025.
Chapter 3, the COPD Inhaler competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the COPD Inhaler breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and COPD Inhaler market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of COPD Inhaler.
Chapter 14 and 15, to describe COPD Inhaler sales channel, distributors, customers, research findings and conclusion.
- 1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global COPD Inhaler Consumption Value by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 Pressurized Metered Dose Inhaler
- 1.3.3 Dry Powder Inhaler
- 1.3.4 Soft Mist Inhaler
- 1.3.5 Atomizer
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global COPD Inhaler Consumption Value by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.4.4 Pharmacy
- 1.5 Global COPD Inhaler Market Size & Forecast
- 1.5.1 Global COPD Inhaler Consumption Value (2020 & 2024 & 2031)
- 1.5.2 Global COPD Inhaler Sales Quantity (2020-2031)
- 1.5.3 Global COPD Inhaler Average Price (2020-2031)
- 2 Manufacturers Profiles
- 2.1 TRELEGY
- 2.1.1 TRELEGY Details
- 2.1.2 TRELEGY Major Business
- 2.1.3 TRELEGY COPD Inhaler Product and Services
- 2.1.4 TRELEGY COPD Inhaler Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 TRELEGY Recent Developments/Updates
- 2.2 TTP
- 2.2.1 TTP Details
- 2.2.2 TTP Major Business
- 2.2.3 TTP COPD Inhaler Product and Services
- 2.2.4 TTP COPD Inhaler Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 TTP Recent Developments/Updates
- 2.3 Consort Medical
- 2.3.1 Consort Medical Details
- 2.3.2 Consort Medical Major Business
- 2.3.3 Consort Medical COPD Inhaler Product and Services
- 2.3.4 Consort Medical COPD Inhaler Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.3.5 Consort Medical Recent Developments/Updates
- 2.4 Cambridge Consultants
- 2.4.1 Cambridge Consultants Details
- 2.4.2 Cambridge Consultants Major Business
- 2.4.3 Cambridge Consultants COPD Inhaler Product and Services
- 2.4.4 Cambridge Consultants COPD Inhaler Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.4.5 Cambridge Consultants Recent Developments/Updates
- 2.5 Inhalexper
- 2.5.1 Inhalexper Details
- 2.5.2 Inhalexper Major Business
- 2.5.3 Inhalexper COPD Inhaler Product and Services
- 2.5.4 Inhalexper COPD Inhaler Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.5.5 Inhalexper Recent Developments/Updates
- 2.6 3M
- 2.6.1 3M Details
- 2.6.2 3M Major Business
- 2.6.3 3M COPD Inhaler Product and Services
- 2.6.4 3M COPD Inhaler Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.6.5 3M Recent Developments/Updates
- 2.7 Hovione
- 2.7.1 Hovione Details
- 2.7.2 Hovione Major Business
- 2.7.3 Hovione COPD Inhaler Product and Services
- 2.7.4 Hovione COPD Inhaler Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.7.5 Hovione Recent Developments/Updates
- 2.8 Qualicaps
- 2.8.1 Qualicaps Details
- 2.8.2 Qualicaps Major Business
- 2.8.3 Qualicaps COPD Inhaler Product and Services
- 2.8.4 Qualicaps COPD Inhaler Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.8.5 Qualicaps Recent Developments/Updates
- 2.9 Catalent
- 2.9.1 Catalent Details
- 2.9.2 Catalent Major Business
- 2.9.3 Catalent COPD Inhaler Product and Services
- 2.9.4 Catalent COPD Inhaler Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.9.5 Catalent Recent Developments/Updates
- 2.10 Aerovance
- 2.10.1 Aerovance Details
- 2.10.2 Aerovance Major Business
- 2.10.3 Aerovance COPD Inhaler Product and Services
- 2.10.4 Aerovance COPD Inhaler Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.10.5 Aerovance Recent Developments/Updates
- 2.11 VertMarkets
- 2.11.1 VertMarkets Details
- 2.11.2 VertMarkets Major Business
- 2.11.3 VertMarkets COPD Inhaler Product and Services
- 2.11.4 VertMarkets COPD Inhaler Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.11.5 VertMarkets Recent Developments/Updates
- 2.12 Boehringer Ingelheim
- 2.12.1 Boehringer Ingelheim Details
- 2.12.2 Boehringer Ingelheim Major Business
- 2.12.3 Boehringer Ingelheim COPD Inhaler Product and Services
- 2.12.4 Boehringer Ingelheim COPD Inhaler Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.12.5 Boehringer Ingelheim Recent Developments/Updates
- 2.13 AstraZeneca
- 2.13.1 AstraZeneca Details
- 2.13.2 AstraZeneca Major Business
- 2.13.3 AstraZeneca COPD Inhaler Product and Services
- 2.13.4 AstraZeneca COPD Inhaler Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.13.5 AstraZeneca Recent Developments/Updates
- 2.14 Chiesi
- 2.14.1 Chiesi Details
- 2.14.2 Chiesi Major Business
- 2.14.3 Chiesi COPD Inhaler Product and Services
- 2.14.4 Chiesi COPD Inhaler Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.14.5 Chiesi Recent Developments/Updates
- 3 Competitive Environment: COPD Inhaler by Manufacturer
- 3.1 Global COPD Inhaler Sales Quantity by Manufacturer (2020-2025)
- 3.2 Global COPD Inhaler Revenue by Manufacturer (2020-2025)
- 3.3 Global COPD Inhaler Average Price by Manufacturer (2020-2025)
- 3.4 Market Share Analysis (2024)
- 3.4.1 Producer Shipments of COPD Inhaler by Manufacturer Revenue ($MM) and Market Share (%): 2024
- 3.4.2 Top 3 COPD Inhaler Manufacturer Market Share in 2024
- 3.4.3 Top 6 COPD Inhaler Manufacturer Market Share in 2024
- 3.5 COPD Inhaler Market: Overall Company Footprint Analysis
- 3.5.1 COPD Inhaler Market: Region Footprint
- 3.5.2 COPD Inhaler Market: Company Product Type Footprint
- 3.5.3 COPD Inhaler Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
- 4 Consumption Analysis by Region
- 4.1 Global COPD Inhaler Market Size by Region
- 4.1.1 Global COPD Inhaler Sales Quantity by Region (2020-2031)
- 4.1.2 Global COPD Inhaler Consumption Value by Region (2020-2031)
- 4.1.3 Global COPD Inhaler Average Price by Region (2020-2031)
- 4.2 North America COPD Inhaler Consumption Value (2020-2031)
- 4.3 Europe COPD Inhaler Consumption Value (2020-2031)
- 4.4 Asia-Pacific COPD Inhaler Consumption Value (2020-2031)
- 4.5 South America COPD Inhaler Consumption Value (2020-2031)
- 4.6 Middle East & Africa COPD Inhaler Consumption Value (2020-2031)
- 5 Market Segment by Type
- 5.1 Global COPD Inhaler Sales Quantity by Type (2020-2031)
- 5.2 Global COPD Inhaler Consumption Value by Type (2020-2031)
- 5.3 Global COPD Inhaler Average Price by Type (2020-2031)
- 6 Market Segment by Application
- 6.1 Global COPD Inhaler Sales Quantity by Application (2020-2031)
- 6.2 Global COPD Inhaler Consumption Value by Application (2020-2031)
- 6.3 Global COPD Inhaler Average Price by Application (2020-2031)
- 7 North America
- 7.1 North America COPD Inhaler Sales Quantity by Type (2020-2031)
- 7.2 North America COPD Inhaler Sales Quantity by Application (2020-2031)
- 7.3 North America COPD Inhaler Market Size by Country
- 7.3.1 North America COPD Inhaler Sales Quantity by Country (2020-2031)
- 7.3.2 North America COPD Inhaler Consumption Value by Country (2020-2031)
- 7.3.3 United States Market Size and Forecast (2020-2031)
- 7.3.4 Canada Market Size and Forecast (2020-2031)
- 7.3.5 Mexico Market Size and Forecast (2020-2031)
- 8 Europe
- 8.1 Europe COPD Inhaler Sales Quantity by Type (2020-2031)
- 8.2 Europe COPD Inhaler Sales Quantity by Application (2020-2031)
- 8.3 Europe COPD Inhaler Market Size by Country
- 8.3.1 Europe COPD Inhaler Sales Quantity by Country (2020-2031)
- 8.3.2 Europe COPD Inhaler Consumption Value by Country (2020-2031)
- 8.3.3 Germany Market Size and Forecast (2020-2031)
- 8.3.4 France Market Size and Forecast (2020-2031)
- 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
- 8.3.6 Russia Market Size and Forecast (2020-2031)
- 8.3.7 Italy Market Size and Forecast (2020-2031)
- 9 Asia-Pacific
- 9.1 Asia-Pacific COPD Inhaler Sales Quantity by Type (2020-2031)
- 9.2 Asia-Pacific COPD Inhaler Sales Quantity by Application (2020-2031)
- 9.3 Asia-Pacific COPD Inhaler Market Size by Region
- 9.3.1 Asia-Pacific COPD Inhaler Sales Quantity by Region (2020-2031)
- 9.3.2 Asia-Pacific COPD Inhaler Consumption Value by Region (2020-2031)
- 9.3.3 China Market Size and Forecast (2020-2031)
- 9.3.4 Japan Market Size and Forecast (2020-2031)
- 9.3.5 South Korea Market Size and Forecast (2020-2031)
- 9.3.6 India Market Size and Forecast (2020-2031)
- 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
- 9.3.8 Australia Market Size and Forecast (2020-2031)
- 10 South America
- 10.1 South America COPD Inhaler Sales Quantity by Type (2020-2031)
- 10.2 South America COPD Inhaler Sales Quantity by Application (2020-2031)
- 10.3 South America COPD Inhaler Market Size by Country
- 10.3.1 South America COPD Inhaler Sales Quantity by Country (2020-2031)
- 10.3.2 South America COPD Inhaler Consumption Value by Country (2020-2031)
- 10.3.3 Brazil Market Size and Forecast (2020-2031)
- 10.3.4 Argentina Market Size and Forecast (2020-2031)
- 11 Middle East & Africa
- 11.1 Middle East & Africa COPD Inhaler Sales Quantity by Type (2020-2031)
- 11.2 Middle East & Africa COPD Inhaler Sales Quantity by Application (2020-2031)
- 11.3 Middle East & Africa COPD Inhaler Market Size by Country
- 11.3.1 Middle East & Africa COPD Inhaler Sales Quantity by Country (2020-2031)
- 11.3.2 Middle East & Africa COPD Inhaler Consumption Value by Country (2020-2031)
- 11.3.3 Turkey Market Size and Forecast (2020-2031)
- 11.3.4 Egypt Market Size and Forecast (2020-2031)
- 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
- 11.3.6 South Africa Market Size and Forecast (2020-2031)
- 12 Market Dynamics
- 12.1 COPD Inhaler Market Drivers
- 12.2 COPD Inhaler Market Restraints
- 12.3 COPD Inhaler Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
- 13 Raw Material and Industry Chain
- 13.1 Raw Material of COPD Inhaler and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of COPD Inhaler
- 13.3 COPD Inhaler Production Process
- 13.4 Industry Value Chain Analysis
- 14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 COPD Inhaler Typical Distributors
- 14.3 COPD Inhaler Typical Customers
- 15 Research Findings and Conclusion
- 16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
- 16.3 Disclaimer
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook